A phase I/II study of abemaciclib, a CDK4/6 inhibitor, in participants with HIV-associated and HIV-negative Kaposi sarcoma.

Authors: Ramya Ramaswami, Jose Mercado-Matos, Kathryn Lurain, Anaida Widell, Irene Ekwede, Ijeoma Agwu, Margaret Namubiru, Thomas A. Odeny, Crystal Lu, Denise Whitby, Robert Yarchoan

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.11505

Source: Full article

---

Abstract

11505